Jonathan Brough
Dallas, TXNPI 1447203823
Payments from drug & device makers
$2,951in general payments, 2019–2025
Across 154 payments — averaging $19.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$596
- Sumitomo Pharma America, Inc.$364
- Pfizer$329
- Astellas Pharma US Inc$167
- Sage Therapeutics, LLC$147
- Mayne Pharma Commercial LLC$145
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,938100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $596 |
| Sumitomo Pharma America, Inc. | 20 | $364 |
| Pfizer | 18 | $329 |
| Astellas Pharma US Inc | 9 | $167 |
| Sage Therapeutics, LLC | 9 | $147 |
| Mayne Pharma Commercial LLC | 6 | $145 |
| Myovant Sciences Inc. | 7 | $135 |
| Organon | 6 | $127 |
| Shield Therapeutics Inc | 2 | $103 |
| Daiichi Sankyo Inc. | 5 | $102 |
| Therapeuticsmd, Inc. | 5 | $68 |
| Coopersurgical, Inc. | 3 | $59 |
| Millicent US Inc | 4 | $58 |
| Hologic Sales And Service, LLC | 2 | $43 |
| Agile Therapeutics, Inc. | 3 | $40 |
| Merck | 3 | $37 |
| Avanos Medical | 1 | $34 |
| Avion Pharmaceuticals | 2 | $34 |
| Exeltis, USA Inc. | 2 | $33 |
| Duchesnay USA Incorporated | 2 | $31 |
| Lilly USA, LLC | 1 | $25 |
| Innovation Technologies Inc | 1 | $25 |
| Biom'up France SAS | 1 | $24 |
| Johnson & Johnson | 1 | $23 |
| Davol Inc. | 1 | $21 |
| Bayer | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Lupin Inc. | 1 | $19 |
| Medtronic | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Teleflex LLC | 1 | $16 |
| Kedrion Biopharma Inc. | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $16 |
| BD | 1 | $15 |
| Convatec Inc. | 1 | $12 |
| Minerva Surgical, Inc | 1 | $11 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $808 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.